ESGAR consensus statement on MR imaging in primary sclerosing cholangitis - Takeaways - MDSpire

ESGAR consensus statement on MR imaging in primary sclerosing cholangitis

  • By

  • Davide Ippolito

  • Cesare Maino

  • Lionel Arrivé

  • Ahmed Ba-Ssalamah

  • Roberto Cannella

  • Alessandro Furlan

  • Aristeidis Grigoriadis

  • Martina Pezzullo

  • Sarah Pöetter Lang

  • Sabine Schmidt Kobbe

  • Federica Vernuccio

  • Maria Antonietta Bali

  • April 26, 2025

  • 0 min

Share

  • 1

    Primary sclerosing cholangitis (PSC) is a cholestatic liver disease characterized by biliary inflammation and fibrosis, leading to liver failure.

  • 2

    MR imaging with cholangiopancreatography (MRCP) is now the recommended diagnostic modality for PSC, replacing endoscopic retrograde cholangiopancreatography (ERCP).

  • 3

    The large-duct subtype of PSC has a more favorable prognosis compared to the small-duct subtype, which requires liver biopsy for diagnosis.

  • 4

    The ESGAR Working Group aims to standardize MR imaging protocols and reporting for PSC to improve communication and quality of care.

  • 5

    The consensus statement includes guidelines on MR acquisition, interpretation, and structured reporting for patients with suspected or diagnosed large-duct PSC.

Original Source(s)

ESGAR consensus statement on MR imaging in primary sclerosing cholangitis

  • by Davide Ippolito, Cesare Maino, Lionel Arrivé, Ahmed Ba-Ssalamah, Roberto Cannella, Alessandro Furlan, Aristeidis Grigoriadis, Martina Pezzullo, Sarah Pöetter Lang, Sabine Schmidt Kobbe, Federica Vernuccio, Maria Antonietta Bali

  • April 26, 2025

Related Content

A new method to estimate the histological stage of primary biliary cholangitis

LDL-C and TC Mediate the Risk of PNPLA3 Inhibition in Cardiovascular Diseases

NAFLD vs MASLD (Metabolic Dysfunction–Associated Steatotic Liver Disease)—Why the Need for a Change of Nomenclature?